Neurocrine Biosciences NBIX Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Neurocrine Biosciences’s reported figures.
Based on trailing twelve months.
The official record: Neurocrine Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neurocrine Biosciences's earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neurocrine Biosciences's earnings yield?
- Neurocrine Biosciences (NBIX) reported earnings yield of 5.1% in Q1 2026.
- How has Neurocrine Biosciences's earnings yield changed year-over-year?
- Neurocrine Biosciences's earnings yield increased by 82.4% year-over-year, from 2.8% to 5.1%.
- What is the long-term trend for Neurocrine Biosciences's earnings yield?
- Over 4 years (2021 to 2025), Neurocrine Biosciences's earnings yield has grown at a -4.5% compound annual growth rate (CAGR), from 14.4% to 12%.
- What does earnings yield mean?
- The company's annual profit as a percentage of its market price — the flip side of the P/E.
- How do you interpret earnings yield?
- Higher means more earnings per dollar invested. Easy to compare directly against bond yields to judge the relative attractiveness of equity.
- How does earnings yield compare across companies?
- Comparable across profitable companies and against fixed-income yields; undefined when earnings are negative.